Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication vulnerability where the software does not perform authentication for functionality that requires a provable user identity, where it may allow a remote attacker to gain unauthorized access to various Alaris Syringe pumps and impact the intended operation of the pump when it is connected to a terminal server via the serial port
Published Aug 23, 2018
9.4
CRITICALCVSS 3.0
EPSS 3.06%
Description
Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication vulnerability where the software does not perform authentication for functionality that requires a provable user identity, where it may allow a remote attacker to gain unauthorized access to various Alaris Syringe pumps and impact the intended operation of the pump when it is connected to a terminal server via the serial port.
Affected products
- Vendor Becton, Dickinson and Company Product Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA Defaultn/a
- Version Version 2.3.6 and priorStatusaffectedConstraints-
- Version
Default status is the baseline for the product, each version can override it (e.g. patched versions marked unaffected).
| Vendor | Product | Default status | Versions | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Becton, Dickinson and Company | Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA | n/a |
|
Configuration 1
- ≤ 2.3.6
Configuration 2
- ≤ 2.3.6
Configuration 3
- ≤ 2.3.6
Configuration 4
- ≤ 2.3.6
Running on/with
- n/a
No data.
No Red Hat product state for this CVE.
No package ranges for this CVE.
Remediation
No remediation recorded yet.
Metrics
No CVSS v4.0 score for this CVE.
No CVSS v3.1 score for this CVE.
CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H
AV:N/AC:L/Au:N/C:P/I:P/A:P
This CVE is not in the KEV list.
No CISA SSVC assessment for this CVE yet.
Estimated probability of exploitation in the wild in the next 30 days (FIRST EPSS). As of Oct 1, 2026.
Score over time
2021–2026- EPSS v1
- EPSS v2
- EPSS v3
- EPSS v4
- EPSS v5
Percentile over time
- EPSS v1
- EPSS v2
- EPSS v3
- EPSS v4
- EPSS v5
Table of values (20 key points)
Flat stretches are collapsed; showing up to 120 newest points.
| Date | Score | Percentile | Model |
|---|---|---|---|
| Oct 1, 2026 | 3.06% (0.03058) | 87.13th | v5 (v2026.06.15) |
| Jun 15, 2026 | 3.06% (0.03058) | 85.83th | v5 (v2026.06.15) |
| May 15, 2026 | 5.53% (0.05528) | 90.34th | v4 (v2025.03.14) |
| Mar 19, 2025 | 7.72% (0.07718) | 90.85th | v4 (v2025.03.14) |
| Mar 17, 2025 | 6.47% (0.06469) | 90.39th | v4 (v2025.03.14) |
| Jul 20, 2024 | 0.97% (0.00969) | 83.53th | v3 (v2023.03.01) |
| Feb 23, 2024 | 0.97% (0.00969) | 82.88th | v3 (v2023.03.01) |
| Jan 14, 2024 | 0.92% (0.00918) | 81.12th | v3 (v2023.03.01) |
| Sep 21, 2023 | 1.70% (0.01701) | 86.24th | v3 (v2023.03.01) |
| Aug 17, 2023 | 1.23% (0.01234) | 83.71th | v3 (v2023.03.01) |
| Jun 29, 2023 | 1.08% (0.01078) | 82.25th | v3 (v2023.03.01) |
| Mar 7, 2023 | 1.15% (0.01146) | 82.55th | v3 (v2023.03.01) |
| Mar 6, 2023 | 1.14% (0.01136) | 59.45th | v2 (v2022.01.01) |
| Oct 18, 2022 | 1.14% (0.01136) | 58.28th | v2 (v2022.01.01) |
| Apr 1, 2022 | 1.14% (0.01136) | 56.27th | v2 (v2022.01.01) |
| Feb 4, 2022 | 1.14% (0.01136) | 34.23th | v2 (v2022.01.01) |
| Feb 3, 2022 | 1.05% (0.01046) | 28.66th | v1 |
| Jan 6, 2022 | 1.05% (0.01046) | 28.03th | v1 |
| Sep 1, 2021 | 1.05% (0.01046) | 65.02th | v1 |
| Apr 14, 2021 | 1.05% (0.01046) | 0.00th | v1 |
References (3)
- http://www.bd.com/en-us/support/product-security-and-privacy/product-security-bulletin-for-various-alaris-plus-syringe-pumps-sold-and-in-use-outside-the-united-states x_refsource_CONFIRMVendor Advisory
- http://www.securityfocus.com/bid/105147 vdb-entryx_refsource_BIDThird Party AdvisoryVDB Entry
- https://ics-cert.us-cert.gov/advisories/ICSMA-18-235-01 x_refsource_MISCThird Party AdvisoryUS Government Resource
| Link | Providers | Tags |
|---|---|---|
| http://www.bd.com/en-us/support/product-security-and-privacy/product-security-bulletin-for-various-alaris-plus-syringe-pumps-sold-and-in-use-outside-the-united-states | x_refsource_CONFIRMVendor Advisory | |
| http://www.securityfocus.com/bid/105147 | vdb-entryx_refsource_BIDThird Party AdvisoryVDB Entry | |
| https://ics-cert.us-cert.gov/advisories/ICSMA-18-235-01 | x_refsource_MISCThird Party AdvisoryUS Government Resource |
Change history (0)
No recorded changes yet.